Drugs that contain Obeticholic Acid

1. List of Ocaliva drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US7138390 INTERCEPT PHARMS INC Steroids as agonists for FXR
Nov, 2022

(6 months ago)

USRE48286 INTERCEPT PHARMS INC Steroids as agonists for FXR
Feb, 2027

(3 years from now)

US10174073 INTERCEPT PHARMS INC Preparation and uses of obeticholic acid
Jun, 2033

(10 years from now)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8058267 INTERCEPT PHARMS INC Steroids as agonists for FXR
Feb, 2022

(1 year, 3 months ago)

US8377916 INTERCEPT PHARMS INC Steroids as agonists for FXR
Feb, 2022

(1 year, 3 months ago)

US9238673 INTERCEPT PHARMS INC Preparation and uses of obeticholic acid
Jun, 2033

(10 years from now)

US10047117 INTERCEPT PHARMS INC Preparation and uses of obeticholic acid
Sep, 2033

(10 years from now)

US10758549 INTERCEPT PHARMS INC Compositions of obeticholic acid and methods of use
Apr, 2036

(12 years from now)

US10751349 INTERCEPT PHARMS INC Compositions of obeticholic acid and methods of use
Apr, 2036

(12 years from now)

US10052337 INTERCEPT PHARMS INC Compositions of obeticholic acid and methods of use
Apr, 2036

(12 years from now)

Do you want to check out OCALIVA patents from before 2022?
Exclusivity Exclusivity Expiration
Orphan Drug Exclusivity (ODE) May 27, 2023

Market Authorisation Date: 27 May, 2016

Treatment: Treatment of primary biliary cholangitis (pbc); Treatment of primary biliary cholangitis (pbc) in combination with ursodeoxycholic acid (udca) in adults with an inadequate response to udca, or as mono...

Dosage: TABLET;ORAL

How can I launch a generic of OCALIVA before it's patent expiration?
More Information on Dosage

OCALIVA family patents

33

United States

11

Japan

9

Australia

9

European Union

6

Israel

6

Korea, Republic of

6

Canada

6

Singapore

EA

4

EA

4

Chile

4

Mexico

4

Brazil

4

China

3

Colombia

3

New Zealand

3

Philippines

2

Denmark

2

Spain

2

Morocco

2

Norway

2

Taiwan

1

Ecuador

1

India

1

El Salvador

1

Netherlands

1

Tunisia

1

Peru

1

Costa Rica

1

Austria

1

Nicaragua

1

Portugal

1

Poland

1

Hong Kong

1

Slovenia

1

Germany

1

Argentina

1

South Africa

1

Belgium

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic